Fabrizio Benedetti

Fabrizio Benedetti's AcademicInfluence.com Rankings

Fabrizio Benedetti

Biology

#8793

World Rank

#11924

Historical Rank

Neuroscience

#1241

World Rank

#1285

Historical Rank

biology Degrees

Download Badge

Biology

Fabrizio Benedetti's Degrees

PhD Neuroscience University of Milan
Masters Psychology University of Turin
Bachelors Biology University of Bologna

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Fabrizio Benedetti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Fabrizio Benedetti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A comprehensive review of the placebo effect: recent advances and current thought. (2008) (1041)
Biological, clinical, and ethical advances of placebo effects (2010) (1041)
Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems (1999) (823)
Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses (2003) (720)
Neurobiological Mechanisms of the Placebo Effect (2005) (677)
Overt versus covert treatment for pain, anxiety, and Parkinson's disease (2004) (521)
New Insights into the Placebo and Nocebo Responses (2008) (520)
When words are painful: Unraveling the mechanisms of the nocebo effect (2007) (516)
Placebos and painkillers: is mind as real as matter? (2005) (452)
Response variability to analgesics: a role for non-specific activation of endogenous opioids (2001) (422)
Response expectancies in placebo analgesia and their clinical relevance (2001) (417)
How prior experience shapes placebo analgesia (2006) (375)
The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect (2006) (374)
Somatotopic Activation of Opioid Systems by Target-Directed Expectations of Analgesia (1999) (372)
The role of learning in nocebo and placebo effects (2008) (368)
Placebo analgesia induced by social observational learning (2009) (335)
Mechanisms of placebo and placebo-related effects across diseases and treatments. (2008) (332)
Placebo and the new physiology of the doctor-patient relationship. (2013) (320)
How Placebos Change the Patient's Brain (2011) (306)
Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective (2006) (306)
The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia (1996) (287)
Nocebo hyperalgesia: how anxiety is turned into pain (2007) (286)
Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus (2004) (281)
Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus (2018) (249)
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors (2011) (240)
How the number of learning trials affects placebo and nocebo responses (2010) (237)
THE NEUROBIOLOGY OF PLACEBO ANALGESIA: FROM ENDOGENOUS OPIOIDS TO CHOLECYSTOKININ (1997) (228)
Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome. (2003) (216)
Placebo Effects: From the Neurobiological Paradigm to Translational Implications (2014) (212)
Potentiation of placebo analgesia by proglumide (1995) (210)
A systematic review of adverse events in placebo groups of anti-migraine clinical trials (2009) (209)
Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide (1997) (208)
Recent developments in pain in dementia (2005) (206)
Pain threshold and tolerance in Alzheimer's disease (1999) (203)
Pain in dementia (2009) (179)
Activation likelihood estimation meta‐analysis of brain correlates of placebo analgesia in human experimental pain (2013) (179)
Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. (1997) (170)
How the Doctor’s Words Affect the Patient’s Brain (2002) (164)
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients (2002) (157)
Mechanisms of the placebo response and their impact on clinical trials and clinical practice (2005) (149)
Neurophysiologic assessment of nerve impairment in posterolateral and muscle-sparing thoracotomy. (1998) (147)
Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain (1998) (143)
Inducing placebo respiratory depressant responses in humans via opioid receptors (1999) (143)
Placebo and Nocebo Effects (2014) (141)
Opioid-Mediated Placebo Responses Boost Pain Endurance and Physical Performance: Is It Doping in Sport Competitions? (2007) (134)
Neural bases of conditioned placebo analgesia (2010) (129)
The placebo response: how words and rituals change the patient's brain. (2011) (126)
Placebo Effects: Understanding the mechanisms in health and disease (2008) (122)
Pain reactivity in Alzheimer patients with different degrees of cognitive impairment and brain electrical activity deterioration (2004) (115)
Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects (2016) (114)
Placebo analgesia and the heart (2003) (113)
The top‐down influence of ergogenic placebos on muscle work and fatigue (2008) (113)
Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems (2013) (100)
Postoperative pain and superficial abdominal reflexes after posterolateral thoracotomy. (1997) (97)
Placebo manipulations reduce hyperalgesia in neuropathic pain (2012) (97)
Pain anticipation: An activation likelihood estimation meta‐analysis of brain imaging studies (2015) (96)
Placebo analgesia (2006) (95)
Autonomic responses and pain perception in Alzheimer’s disease (2000) (94)
Placebo mechanisms across different conditions: from the clinical setting to physical performance (2011) (93)
Mechanisms of the placebo response. (2013) (85)
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway (2014) (83)
Hidden Administration of Drugs (2011) (83)
The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression (1998) (82)
Placebo Effects : Biological , Clinical and Ethical Advances (2010) (79)
Inferior olive inactivation decreases the excitability of the intracerebellar and lateral vestibular nuclei in the rat. (1983) (76)
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti‐parkinsonian placebo response (2009) (76)
Pain and the context (2014) (76)
Expectations and positive emotional feelings accompany reductions in ongoing and evoked neuropathic pain following placebo interventions (2014) (74)
Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? (2012) (70)
The Patient's Brain: The neuroscience behind the doctor-patient relationship (2010) (69)
Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region (2004) (69)
Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region (2005) (68)
Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors (2011) (62)
Placebo Effects: 2nd Edition: Understanding the mechanisms in health and disease (2014) (62)
Teaching neurons to respond to placebos (2016) (61)
Pain perception and tolerance in patients with frontotemporal dementia (2009) (61)
Placebo and Nocebo Effects: A Complex Interplay Between Psychological Factors and Neurochemical Networks (2015) (60)
Era of biosimilars in rheumatology: reshaping the healthcare environment (2019) (60)
Different contexts, different pains, different experiences (2016) (60)
Placebo-induced improvements: how therapeutic rituals affect the patient's brain. (2012) (59)
Processing of tactile spatial information with crossed fingers. (1985) (59)
Consensus statement on placebo effects in sports and exercise: The need for conceptual clarity, methodological rigour, and the elucidation of neurobiological mechanisms (2018) (57)
Placebo and endogenous mechanisms of analgesia. (2007) (56)
Temporal Changes in Movement Time during the Switch of the Stimulators in Parkinson’s Disease Patients Treated by Subthalamic Nucleus Stimulation (2003) (53)
There is less thalamic degeneration in neonatal-lesioned than in adult-lesioned cats after cerebral hemispherectomy (1986) (52)
Experimental designs and brain mapping approaches for studying the placebo analgesic effect (2008) (49)
The placebo response: neurobiological and clinical issues of neurological relevance. (2009) (48)
No prefrontal control, no placebo response (2010) (45)
Cholecystokinin Type A and Type B Receptors and Their Modulation of Opioid Analgesia (1997) (45)
Repeatability of autonomic responses to pain anticipation and pain stimulation (2006) (45)
Context matters: the psychoneurobiological determinants of placebo, nocebo and context-related effects in physiotherapy (2020) (43)
What Is the Role of the Placebo Effect for Pain Relief in Neurorehabilitation? Clinical Implications From the Italian Consensus Conference on Pain in Neurorehabilitation (2018) (41)
Role of explicit verbal information in conditioned analgesia (2015) (39)
Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data (2021) (39)
Preventing motor training through nocebo suggestions (2012) (37)
Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials (2015) (37)
Characterization of the thalamic–subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients (2014) (36)
Inferior olive lesion induces long-lasting functional modification in the Purkinje cells (2004) (35)
Why We should Assess Patients’ Expectations in Clinical Trials (2017) (35)
What do you expect from this treatment? Changing our mind about clinical trials (2007) (35)
Placebo‐induced decrease in fatigue: evidence for a central action on the preparatory phase of movement (2015) (34)
Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience (2011) (32)
Nonlinear analysis of electroencephalogram at rest and during cognitive tasks in patients with schizophrenia. (2012) (32)
New insights into placebo analgesia (2003) (31)
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning (2017) (30)
What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus (2020) (30)
Localization of tactile stimuli and body parts in space: two dissociated perceptual experiences revealed by a lack of constancy in the presence of position sense and motor activity. (1988) (27)
Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders (2017) (27)
A systematic review of adverse events in the placebo arm of donepezil trials: the role of cognitive impairment (2012) (26)
Perceptual learning following a long-lasting tactile reversal. (1991) (24)
High-altitude headache: the effects of real vs sham oxygen administration (2015) (23)
Placebo and nocebo effects: an introduction to psychological and biological mechanisms. (2014) (23)
Responding to nocebos through observation: Social contagion of negative emotions (2013) (23)
Collateral reinnervation in the olivocerebellar pathway in the rat. (1983) (23)
The placebo response: science versus ethics and the vulnerability of the patient (2012) (23)
Nature of the placebo and nocebo effect in relation to functional neurologic disorders. (2016) (22)
Tactile Diplopia (Diplesthesia) on the Human Fingers (1986) (22)
The placebo in practice: how to use it in clinical routine (2012) (20)
Placebo-Induced Analgesia: Methodology, Neurobiology, Clinical Use, and Ethics (2003) (19)
The postnatal emergence of a functional somatosensory representation in the superior colliculus of the mouse. (1991) (18)
The neurobiological underpinnings of placebo and nocebo effects. (2019) (18)
Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain (2017) (17)
The development of the somatosensory representation in the superior colliculus of visually deprived mice. (1992) (17)
The Effects of Manipulating Verbal Suggestions on Physical Performance (2014) (16)
The Importance of Considering the Effects of Perceived Group Assignment in Placebo-Controlled Trials (2005) (16)
European Headache Federation recommendations for placebo and nocebo terminology (2020) (16)
Nocebo and the contribution of psychosocial factors to the generation of pain (2019) (16)
Orienting Behaviour and Superior Colliculus Sensory Representations in Mice with the Vibrissae Bent into the Contralateral Hemispace (1995) (16)
Exploration of a rod with crossed fingers (1988) (14)
Creating placebo responders and nonresponders in the laboratory: boons and banes. (2014) (14)
Metabolic activity of intracerebellar nuclei in the rat: Effects of inferior olive inactivation (2004) (14)
Mario Tiengo, M.D. 1922–2010 (2011) (14)
Quantitative EEG Responses to Ischaemic Arm Stress in Migraine (2001) (14)
Drugs and placebos: what's the difference? (2014) (14)
Incorporating methods and findings from neuroscience to better understand placebo and nocebo effects in sport (2020) (13)
Spatial Organization of the Diplesthetic and Nondiplesthetic Areas of the Fingers (1986) (13)
How do placebos work? (2018) (12)
Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability (2021) (12)
The placebo response in conditions other than pain (2005) (12)
Placebo response: relevance to the rheumatic diseases. (2008) (12)
The effect of temporal information on placebo analgesia and nocebo hyperalgesia. (2020) (11)
Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad. (2021) (11)
Understanding the mechanisms of placebo and nocebo effects. (2020) (11)
The Effects of Early Postnatal Modification of Body Shape on the Somatosensory—Visual Organization in Mouse Superior Colliculus (1995) (11)
Nocebo effects: more investigation is needed (2018) (11)
Placebo and nocebo (2009) (11)
Magnitude, response, and psychological determinants of placebo effects in chronic low-back pain: a randomised, double-blinded, controlled trial (2019) (11)
Reorganization of Tactile Perception following the Simulated Amputation of One Finger (1991) (10)
Critical Life Functions: Can Placebo Replace Oxygen? (2018) (10)
Placebo effects, Second Edition (2014) (10)
Targeted Use of Placebo Effects Decreases Experimental Itch in Atopic Dermatitis Patients: A Randomized Controlled Trial (2021) (10)
Decreased Sensitivity of 5‐HT1D Receptors in Chronic Tension‐Type Headache (2002) (9)
Between placebo and nocebo: Response to control treatment is mediated by amygdala activity and connectivity (2019) (9)
Placebo Analgesia—Understanding the Mechanisms and Implications for Clinical Practice (2009) (9)
S.3.02 Mechanisms of placebo and placebo related effects across diseases and treatments (2010) (8)
The sensory and affective components of pain (1997) (8)
Attempting to Separate Placebo Effects from Exercise in Chronic Pain: A Systematic Review and Meta-analysis (2021) (8)
Placebo and nocebo effects: Unfolding the complex interplay between distinct phenotypes and physiological mechanisms. (2016) (8)
Placebo responders and nonresponders: what's new? (2018) (8)
600 PAIN PERCEPTION AND TOLERANCE IN PATIENTS WITH FRONTOTEMPORAL DEMENTIA (2009) (8)
Placebo responses in animals (2012) (8)
Different routes of administration in chronic migraine prevention lead to different placebo responses: a meta-analysis. (2021) (7)
Nocebo and Pain (2016) (7)
Pain and the Placebo/Nocebo Effect (2013) (7)
‘External timing’ of placebo analgesia in an experimental model of sustained pain (2021) (6)
The Dangerous Side of Placebo Research: Is Hard Science Boosting Pseudoscience? (2019) (6)
Nonlinear analysis of electroencephalogram in frontotemporal lobar degeneration (2014) (6)
Beecher as Clinical Investigator: Pain and the Placebo Effect (2016) (5)
Differential Formation of Topographic Maps in the Cerebral Cortex and Superior Colliculus of the Mouse by Temporally Correlated Tactile‐Tactile and Tactile‐Visual Inputs (1995) (5)
Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial (2021) (5)
Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences. (2019) (5)
Receiving the therapy: the activation of expectation and placebo mechanisms (2010) (5)
American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2003) (4)
The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: A meta‐analysis (2019) (4)
Implantation of artificial whiskers on the ears of newborn mice induces visual re-mapping in the superior colliculus (1994) (4)
Placebos and treatment of pain. (2004) (4)
Sensory and Motor Functions of the Hand (1994) (4)
Functional Changes of the Purkinje Cell Following Climbing Fiber Deafferentation (1984) (3)
I expect what you expect: An electrophysiological study on social expectation of pain. (2020) (3)
Electroencephalographic responses to intraoperative subthalamic stimulation (2006) (3)
Placebos and Movies: What Do They Have in Common? (2021) (3)
447 HYPERALGESIC AND ALLODYNIC EFFECTS OF NOCEBO SUGGESTIONS (2007) (3)
Hypothalamic‐Pituitary‐Adrenal Activity in Adverse Events Reporting After Placebo Administration (2021) (3)
Postthoracoscopy pain: is TENS the answer? (1997) (3)
What is the relative contribution of biological and psychosocial factors to the generation of hypoxia headache? (2018) (3)
Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice (2018) (3)
Personality: Neurobehavioural Foundation and Pharmacological Protocols (2014) (3)
Placebo and nocebo effects: how the doctor's words affect the patient's brain (2007) (2)
L’effetto placebo (2008) (2)
The need to investigate nocebo effects in more detail (2019) (2)
Meeting the therapist: a look into trust, hope, empathy, and compassion mechanisms (2010) (2)
Defence mechanisms of the body in the course of evolution: from cellular to social responses (2010) (2)
The Neural Matrix of Pain Processing and Placebo Analgesia: Implications for Clinical Practice (2005) (2)
The subthalamic nucleus and the placebo effect in Parkinson's disease. (2021) (2)
Goal directed motor behavior and its adaptation following reversed tactile perception in man (2004) (2)
Placebo and nocebo responses in Parkinson's disease (2020) (2)
Placebo effects: the need for a new perspective and conceptualization (2018) (2)
Can Low Placebo Responsiveness in Dementia be Exploited in Clinical Trials? (2014) (1)
The placebo effect in breath holding: a preliminary behavioral investigation (2020) (1)
The Special Case of High-Altitude Headache (2019) (1)
Are Nocebo Effects in Adulthood Linked to Prenatal Maternal Cortisol Levels? (2022) (1)
Dopamine Dysfunction in Schizophrenia: From Genetic Susceptibility to Cognitive Impairment (2016) (1)
What is the role of placebo in neurotherapeutics? (2021) (1)
“Consensus on Placebo and Nocebo Effects Connects Science with Practice:” Reply to “Questioning the Consensus on Placebo and Nocebo Effects” (2021) (1)
Drugs and Placebos: What’s the Difference? (2022) (1)
Pain and the Placebo Effect (2009) (1)
The nocebo effect: How stress modulates pain (2007) (1)
Neurochemistry of Placebo Analgesia: Opioids, Cannabinoids and Cholecystokinin (2013) (1)
Placebo/Nocebo: a two-side coin in the clinician’s hand (2010) (1)
Words and Drugs: Same Mechanisms of Action? (2016) (1)
Comprar The Patient's Brain The neuroscience behind the doctor-patient relationship | Fabrizio Benedetti | 9780199579518 | Oxford University Press (2010) (1)
Placebos and Nocebos in Headaches (2019) (1)
Testing for blinding is the only way to determine whether a trial is blind (2017) (1)
A3. Learning and the Placebo Effect (2010) (0)
Learning to respond to placebos in sensory and motor system (2006) (0)
Supplementary Information for “ Decreased activity of single subthalamic nucleus neurons in Parkinson patients responding to placebo ” (2004) (0)
26 RESPONSIVENESS TO PLACEBOS: LEARNING OR GENETIC TRAIT? (2009) (0)
muscle-sparing thoracotomy Neurophysiologic assessment of nerve impairment in posterolateral and (2009) (0)
How to run a placebo study: a closer look into complex experimental designs (2008) (0)
How to run a placebo study (2020) (0)
P.2.008 Duration over time of learned placebo analgesic responses (2010) (0)
The traditional concept of placebo (2008) (0)
Correction to: Attempting to Separate Placebo Effects from Exercise in Chronic Pain: A Systematic Review and Meta-analysis (2021) (0)
47 CAN WE CREATE PLACEBO RESPONDERS AND NON‐RESPONDERS IN THE LAB? (2010) (0)
2996 – What is the Placebo Effect in Psychiatry? (2013) (0)
Variability in the Placebo Response: The Interesting, the Good, the Bad (2021) (0)
Gastrointestinal and genitourinary disorders (2008) (0)
Treating fear of pain to prevent suffering Gordon JG Asmundson Johan WS (2005) (0)
APPLICATION OF THE DYNAMICAL ANALYSIS OF THE ELECTROENCEPHALOGRAM (EEG) IN THE STUDY OF COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA (2010) (0)
The Temporal Modulation of Nocebo Hyperalgesia in a Model of Sustained Pain (2022) (0)
Opioids in pain, placebo and epilepsy (2006) (0)
Is there a place for placebo analgesia in everyday clinical practice (2011) (0)
Preventing motor training through nocebo suggestions (2012) (0)
Clinical–ethical implications and applications (2008) (0)
Can cardiosympathetic and cardiovagal indices predict the efficacy of vagal nerve stimulation in depression? A pilot study (2008) (0)
Abnormal 5-HT1D receptor function in chronic tension-type headache: A neuroendocrine study with sumatriptan (2001) (0)
Emergence and development of scientific medicine (2010) (0)
REM sleep-related episodes in children with narcolepsy type 1 after treatment with sodium oxybate (2017) (0)
Special medical conditions and therapeutic interventions (2008) (0)
The Neurobiology of Placebo Effects (2018) (0)
Mental and behavioural disorders (2008) (0)
The brain of the demented patient (2010) (0)
Immune and endocrine systems (2008) (0)
Imaging Placebo Responses in the Brain (2010) (0)
Cardiovascular and respiratory system (2008) (0)
The pharmacology of placebos (2018) (0)
Pain anticipation: a possible way to understand the perceptual set of self-regulation and affective mechanisms behind nocebo response. (2015) (0)
Feeling sick: a combination of bottom-up and top-down events (2010) (0)
Predictive Validity (2022) (0)
Culture, Placebo, and Analgesia: Clinical and Ethical Considerations (2012) (0)
Placebo, nocebo, and psychogenic illness (2021) (0)
Books Received (2013) (0)
Ask the Experts: Is there a place for placebo analgesia in everyday clinical practice? (2011) (0)
Placebo Response n Conditions Other Than Pain (0)
733 HOW DURATION OF CONDITIONING TRIALS AFFECTS PLACEBO AND NOCEBO RESPONSIVENESS (2009) (0)
74 THE PLACEBO EFFECT: IT'S TIME FOR CLINICAL IMPLICATIONS AND APPLICATIONS (2006) (0)
Clinical perspectives of cholecystokinin antagonists in pain management (1999) (0)
Electrodiagnostic approaches: Pain-induced heart responses in humans: reliability and repeatability across multiple sessions (2004) (0)
PAIN (1967) (0)
Conscious and unconscious placebo responses (2010) (0)
Placebo Effect (2020) (0)
[Monosialoganglioside (Sygen) in amateur boxers suspended from sport activities]. (1992) (0)
Seeking relief: the activation of motivational and reward circuits (2010) (0)
A brief evolutionary account of medical care (2010) (0)
Placebos in clinical trials: unravelling a complex phenomenon – Authors' reply (2017) (0)
A modern view of placebo and placebo-related effects (2008) (0)
The science of placebos is fuelling quackery (2022) (0)
Diseases of the nervous system (2008) (0)
Placing placebo effects within the context of the doctor–patient relationship as a defence mechanism (2020) (0)
Conscious and unconscious mechanisms in placebo analgesia (2012) (0)
Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone. (2022) (0)
Response to the commentaries by Ader, Bootzin, Kihlstrom, Kirsch, Logan, Moerman, and Roth on Benedetti et al. (2003). (2003) (0)
73 Topical Seminar Summary: MEASURING THE PLACEBO EFFECT, DRUGS THAT ENHANCE IT, AND LESSONS FOR CLINICAL TRIALS AND CLINICAL PRACTICE (2006) (0)
Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis (P9-6.002) (2023) (0)
Response to Comment on: “Attempting to Separate Placebo Effects from Exercise in Chronic Pain: A Systematic Review and Meta-Analysis” (2021) (0)
The neurobiological bases of placebo responses (2010) (0)
9 THE PLACEBO EFFECT: FROM MECHANISMS TO CLINICAL IMPLICATIONS (2007) (0)
Effects of subthalamic stimulation on brain electrical activity during a motor task in Parkinson's disease (2007) (0)
Historical evolution of the scientific investigation of the placebo analgesic effect (2022) (0)
Conscious and unconscious placebo responses: How the ritual of the therapeutic act changes the patient’s brain (2010) (0)
Placebo Effects in Psychology (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Fabrizio Benedetti?

Fabrizio Benedetti is affiliated with the following schools:

University of Milan
University of Florence
University of Turin
University of Bologna

Fabrizio Benedetti's Academic­Influence.com Rankings